North America

Fri
08
Feb

Wesgro optimistic about investment potential of medicinal cannabis

The Western Cape’s investment promotion agency Wesgro says it is optimistic about the potential offered by local production of medicinal cannabis, despite the slow pace of SA’s medicines regulator.

Growing cannabis for medical purposes — be it for research or pharmaceutical production — requires a licence from the SA Health Products Regulatory Authority (Sahpra), but it has yet to issue any. Similarly, any medicinal cannabis products manufactured or sold in SA require approval of the regulator.

Wesgro CEO Tim Harris said there have been several expressions of interest from domestic and foreign medicinal cannabis investors since the health department introduced a legal framework in late 2017.

Fri
08
Feb

Millennials keep pouring money into marijuana stocks

  • Cannabis stocks have gained popularity among investors at Robinhood, a free-trading app popular among younger traders, after the legalization of recreational marijuana in Canada.
  • Over the past week, three of the four most-added stocks on the app were marijuana producers.
  • Millennials are not just buying individual stocks, but also snapping up exchange-traded funds that invest in a portfolio of cannabis-related stocks, according to a marijuana exchange-traded fund founder.
  • MJ ETF, which focuses on investing in global pot-related stocks, also seems to be attracting younger investors.
Fri
08
Feb

Target Group Inc. signs agreement to acquire CannaKorp, Inc.

Target Group Inc. has entered into an agreement to acquire the U.S. and Canadian operations of Massachusetts-based CannaKorp Inc., holder of a patent-pending vaporizing system.

The WISP herbal vaporizing system uses precisely measured, sealed and tested company pods containing dried, ground botanicals, notes a press release from Target Group, a diversified and vertically integrated cannabis acquisition company.

Using the vaporizer and pods together, the statement claims, “gives cannabis users the predictability and assurance to know what they’re inhaling with every use, without the hassle of grinding, measuring or packing.”

Thu
07
Feb

The future of big data in cannabis

People often want to look to hard data to solve the most difficult issues in society. That seems preferable to taking best guesses at predicting the future.

With the legalization of recreational cannabis this past October, the world is looking to Canada for best practices and lessons learned, with regard to recreational and to the country’s longer experience to date with medical cannabis patients.

As the industry continues to evolve, big data is ever more critical in the process to best understand every step of the journey.

Thu
07
Feb

Shoppers want Amazon-brand prescription drugs, medical marijuana and cryptocurrency

Consumers can buy almost anything on Amazon.com Inc., but they would like to be able to purchase more, including prescription drugs, medical marijuana and cryptocurrency, according to an Investing.com study.

Investing.com polled about 1,000 Amazon AMZN, -0.81%   shoppers, both Prime members and non-Prime members. Of the 1,013 respondents to a question asking which products and services they would feel comfortable purchasing beneath an “Amazon” brand, 36.7% said prescription drugs, 29.5% said medical marijuana, 16% said virtual doctor visits and 12.7% were OK with cryptocurrencies.

Thu
07
Feb

The 13 largest pot stocks by market cap

Go ahead and talk about marijuana and marijuana stocks -- it's no longer considered taboo. Following the passage of the Cannabis Act in Canada, and taking into account that two-thirds of all U.S. states have now legalized weed in some capacity, the legal pot industry has been validated as a legitimate business model. As a result, we've seen sales expectations and market caps go through the roof.

Thu
07
Feb

3 marijuana stocks with built-in safety nets

The marijuana industry has come a mighty long way in a very short amount of time. If we look back to 2005, Gallup notes that just a third of all Americans it surveyed wanted to see cannabis legalized in the United States. By 2010, even with favorability toward weed improving, not a single state had given pot the green light at the recreational level. Now, in 2019, marijuana is legal medically in 33 U.S. states, 10 of which also allow adults to consume it, and 2 out of 3 Americans are in favor of its legalization.

Thu
07
Feb

Why cannabis beverages are the next breakthrough for the marijuana industry

Scientists everywhere are researching marijuana and trying to understand all we can about it, writes Joseph Misulonas. That includes its medical benefits, how it affects humans and other things. But the biggest thing people are trying to figure out is how the heck to get it in liquid form.

Thu
07
Feb

Aleafia Health’s first product data science fellow to lead acceleration of research efforts

Dr. Graham Merry, Aleafia Health Inc.’s first-ever product data science fellow, will lead the company’s ongoing medical cannabis research efforts into the development of evidence-based, proprietary treatment methods and products for chronic illnesses.

Leveraging Aleafia Health’s proprietary, 10 million-point medical cannabis patient dataset, Dr. Merry will guide medical cannabis research into chronic illnesses such as pain, insomnia, anxiety and eating disorders, notes a statement from the company.

Wed
06
Feb

Here's the number one reason people use medical marijuana

States allow people to use medical marijuana to treat any number of conditions ranging from HIV/AIDS to cancer to irritable bowel syndrome. But there's one medical reason people use cannabis above all others, writes Joseph Misulonas.

Pages

Subscribe to RSS - North America